The Lancet Haematology

aka Lancet Haematol

The Lancet Haematology is the Lancet's haematology journal, publishing phase 2 and 3 trials in leukaemia, lymphoma and myeloma, transplant studies and global-access commentary on blood cancers.

The Lancet Haematology has appeared monthly since 2014 and publishes randomised and single-arm trials in blood cancers (CAR-T and bispecific follow-up, MDS and myelofibrosis studies), long-term outcomes, and Commissions on haematological care in low-income settings. Elsevier hybrid model.

Publisher

Elsevier

Scope

haematology

Website

www.thelancet.com/journals/lanhae/home

Access model

hybrid

Founded

2014

ISSN

2352-3026

Impact factor (2023)

15.4 · Clarivate Journal Citation Reports 2024 (2023 JIF)

Connected

0top

Nothing links here yet.